| INTRODUC TI ON
Cutaneous melanoma is a malignant neoplasm derived from skin melanocytes. Melanoma cells have a high ability of local invasion and metastasis, even when arise from very small volume tumors (Gray-Schopfer, Wellbrock, & Marais, 2007) . Once disseminated, melanoma is highly resistant to conventional anticancer treatments, and its prognosis is poor (Pollack et al., 2011) . As melanoma can present in young and medium age adults (Lee et al., 2016; Ríos et al., 2013) , it causes disproportionate mortality in such population being responsible of one of the highest rate of loss of potential life for adult-onset cancers (Ekwueme et al., 2011) . Although available therapies for metastatic melanoma have evolved substantially in the last years, especially with the introduction of targeted-and immunotherapies (Hao et al., 2015) , melanoma is still a serious healthcare problem, and melanoma cell behavior is an important subject of research.
Several genetic mutations have been associated with melanoma development and progression. Overall, around 40%-50% of melanomas carry mutations in the BRAF gene. Of these, 90% bear the BRAFV600E mutation (Banzi et al., 2016; Dhomen et al., 2009 ).
About 20% of melanomas harbor mutations in the NRAS gene, mostly affecting codon Q61 (Jakob et al., 2012) . Moreover, many other genetic alterations have been described that confer gain/ loss function of genes that trigger abnormal signaling pathways like KIT, GNAQ/GNA11, CDKN2A, PTEN, NF1, BAP1, among others (Griewank et al., 2014) . Some studies advocate that patients with primary BRAFV600E or NRAS melanoma have worse survival rate compared with wild-type (WT) BRAF melanoma patients (Davies et al., 2002; Long et al., 2011) . However it seems that, once disseminated, BRAF and NRAS mutation status does not influence survival in metastatic melanoma (Carlino et al., 2014) .
The expression of T-type calcium channels (TTCCs) is increased in a number of tumors, where they promote cell proliferation (Dziegielewska, Gray, & Dziegielewski, 2014; Macià, Herreros, Martí, & Cantí, 2015) . Human melanoma cells overexpress Cav3.1 and Cav3.2 isoforms of TTCCs, compared with untransformed melanocytes (Das et al., 2012) . Importantly, TTCC pharmacological blockers not only reduce the proliferation of melanoma cells, but also trigger apoptotic cell death, partially through the activation of caspases (Das et al., 2013) . We found that such apoptotic process is preceded by ER stress and blockade of the autophagic flux (Das et al., 2013) . Therefore, TTCCs may be valuable therapeutic targets against melanoma progression (Das et al., 2012; Das et al., 2013; Macià et al., 2015; Maiques et al., 2017) .
Macroautophagy (hereafter autophagy) is a housekeeping cell process that plays a significant role in tumor progression (Kroemer, Mariño, & Levine, 2010; Mizushima & Komatsu, 2011 ) and resistance to therapy (Amaravadi, 2011; Corazzari et al., 2015; Ma et al., 2011) . Autophagy is constitutively induced in melanoma cells and may be further induced during chemotherapy Das et al., 2013; Ma et al., 2011) . In addition, autophagy blockade results in decreased tumor cell migration and invasion (Lu et al., 2016; Sharifi et al., 2016) . Hence, autophagy modulation is an emerging therapeutic strategy also in melanoma.
Melanoma cell invasion and subsequent metastasis are hallmarks of melanoma dissemination (Chin, Garraway, & Fisher, 2006 ). Snail1 is a major transcription factor that induces epithelialmesenchymal transition (EMT) and has been shown to be crucial during tumor progression and invasion (Cano et al., 2000; Thiery, 2002) . In melanoma cells, Snail1 is upregulated (Poser et al., 2001) and promotes cell motility and invasiveness (Hao, Ha, Kuzel, Garcia, & Persad, 2012; Olmeda, Jordá, Peinado, Fabra, & Cano, 2007) . 
| RE SULTS

| Expression of TTCCs in melanoma cells with different genetic profile
We first studied the expression of TTCCs by RT-PCR in a wide range of melanoma cell lines bearing different molecular features (Table S1 ).
Different levels and patterns were observed in all melanoma cell lines regarding transcripts for Cav3.1 (Figure 1a ), Cav3.2 (Figure 1b) , and Cav3.3 (Figure 1c ) isoforms. However, Cav3.1 levels were frequently higher than in untransformed melanocytes (HEMn-LP). The expression of Cav3.1 and Cav3.3 mRNA was increased in BRAFV600E melanoma cell lines compared with NRASQ61H/K/L/R (Figure 1d-f) , whereas no significant differences were observed regarding Cav3.2 mRNA levels ( Figure 1e ).
Significance
T-type calcium channels (TTCCs) are overexpressed during melanoma progression, but the role they play is still unclear. This study reports an impairment of migration and invasion abilities of the most common genetic melanoma subgroup (BRAF/V600E) when subjected to pharmacological TTCC blockade. It has been long described that BRAF/V600E melanomas have upregulated autophagic flux, and similar results have been observed when autophagy is blocked. These findings show that autophagy and TTCC regulation intersect at some point which seems to be controlled by Snail1. Therefore, this work is at the frontier between basic and translational science and open new therapeutic strategies.
| TTCC blockers block basal autophagy in all melanoma cell lines
Autophagy in melanoma cells is constitutively active (Arindam Das et al., 2013; Maes & Agostinis, 2014) . To study autophagy, we measured LC3I/II, an autophagic marker (Sahani, Itakura, & Mizushima, 2014) , by Western blot (WB) in melanoma cell lines. We observed an increase of LC3II levels in most of the BRAFV600E melanoma (Figure 1g ). When cells were treated with TTCC blockers (mibefradil (Mib) and pimozide (Pim)), increased levels of LC3II and p62 were detected in BRAFV600E (Figure 1h , Figure S1a ) and NRAS (Figure 1i , Figure S1b ) melanoma cell lines. These data are suggestive of autophagy blockade at a step following autophagosome biogenesis.
Treatment of the melanoma cell lines with chloroquine (CQ), that prevents the fusion of autophagosomes (AP) with lysosomes (Boya et al., 2005) , led to similar increases of LC3II and p62 proteins in all cell lines (Figure 1j, k, Figure S1c, d) . To further confirm these changes on autophagy observed by Western blot, LC3B immunofluorescence (IF) was used as a marker for AP (Mizushima, Yoshimori, & Levine, 2010) . A significant increase of AP puncta was observed both in M3 (BRAFV600E) and in Skmel-147 (NRASQ61R) cell lines when they were subjected to Mib or CQ treatment (Figure 1l ). Moreover, addition of chloroquine to mibefradil-treated cultures did not further increase the levels of p62 and LC3II ( Figure S1e ). Taken together, these results indicate that TTCC blockers block autophagy, regardless of the specific mutation present in melanoma cell lines.
F I G U R E 1 TTCCs are expressed in melanoma cell lines and TTCC blockers inhibit macroautophagy. qRT-PCR of (a) Cav3.1, (b) Cav3.2, and (c) Cav3.3 in BRAFV600E-or NRAS-mutated melanoma cell lines and normalized to GAPDH expression. The mRNA levels from melanocytes (HEMn-LP) are shown for comparison. Comparison of the mRNA levels of (d) Cav3.1, (e) Cav3.2, and (f) Cav3.3 between cell line groups. The statistical analysis used was Mann-Whitney test, (*p < .05; n.s non-significant). (g) Analysis of LC3I/II by WB from total protein lysates. WB analysis to test p62 and LC3 protein levels from (h) BRAFV600E and (i) NRAS mutant melanoma cells exposed to mibefradil (Mib, 10 μM) and pimozide (Pim, 10 μM) for 24 hr. (j) BRAFV600E and (k) NRAS mutant melanoma cells treated with CQ (25 μM) for 24 hr. β-actin was used as a loading control. (l) Immunofluorescence images and graphs of LC3B positive puncta in M3 (BRAFV600E) and Skmel-147 (NRASQ61R) cell lines in untreated, Mib or, CQ treatments. AP: Autophagosomes. Statistical analysis was performed using ANOVA and Bonferroni tests (*p < .05; **p < .01; ***p < .001; n.s., non-significant) [Colour figure can be viewed at wileyonlinelibrary.com]
| Autophagy blockade inhibits collective migration of BRAFV600E melanoma cell lines
Cell migration is a key process during melanoma metastasis. We assessed the effect of TTCC blockers on melanoma migration using a wound-healing assay that measures collective migration. Both To further study how autophagy inhibition affects melanoma cell migration, we knocked down Atg5, an autophagy-related protein required for autophagosome formation (Pyo et al., 2005) These results show that mibefradil and CQ decrease single-cell migration in BRAFV600E melanoma cells by blocking the autophagic flux.
| Autophagy blockade inhibits invasion of BRAFV600E melanoma cell lines
We 
| Analysis of expression of TTCCs in biopsies from patients with melanoma
To extend our observations to the clinical settings, we used a cohort of 33 primary and 28 metastatic melanomas biopsies. Such cohort was divided into two main groups according to their BRAF genetic status (mutant BRAFV600E/K vs BRAFWT) analyzed by PCR sequencing (Table S2 ). The expression levels (histoscore) of TTCCs (Cav3.1 and Cav3.2) and LC3 were assessed by IHC. All melanoma samples bearing BRAFV600E/K gene mutations showed a higher immunoexpression of Cav3.1 compared with the WT BRAFWT cohort (Figure 5a,b) , thus confirming our previous results (Maiques et al., 2017) . In contrast, Cav3.2 immunoexpression did not show significant differences between the two groups (Figure 5c,d ).
We additionally checked whether the mutation status of mel- 
| Snail1 expression is higher in BRAFV600E melanomas and decreases upon autophagy blockade
Snail1 plays several roles in cell migration and EMT process (Cano et al., 2000) . To understand if autophagy was regulating cell migra- The statistical analysis was performed using ANOVA and Bonferroni test (*p < .05; **p < .01; ***p < .001; n.s., nonsignificant) Snail1 was reduced in BRAFV600E cell lines that were treated with TTCC blockers (Figure 6c ), or subjected to gene silencing of (Figure 6l ). These results suggest that Snail1 could be essential to impair migration/invasion when autophagy is blocked, particularly by targeting TTCCs. To complement these approaches, we used the publicly available database TCGA and found that Snail1 expression was increased in melanoma biopsies of patients harboring BRAFV600E mutation, compared to that BRAFWT (Figure 6n ).
Cell migration and invasion are key steps during metastatic dissemination; therefore, we performed Snail1 IHC analysis in metastatic vs primary melanoma biopsies. Snail1 nuclear staining (active form) was significantly higher in metastatic compared with primary lesions only in patients harboring BRAFV600E/K mutations (Figure 6o ).
Moreover, we observed a higher Snail1 score in BRAFV600E/K metastasis, compared with BRAFWT metastatic tumors. These results indicate an important role of Snail1 during metastatic spread of BRAFV600E melanomas.
| D ISCUSS I ON
We have previously shown that the immunoexpression of TTCCs increases gradually from melanocytes to primary and metastatic melanoma biopsies and relates to poor prognosis (Maiques et al., 2017 Corazzari et al., 2015; Giglio, Fimia, Lovat, Piacentini, & Corazzari, 2015; Maddodi et al., 2010) . Thus, autophagy inhibition could be a therapeutic tool to enhance the antitumor activity of BRAF inhibitors. Furthermore, this strategy may also prevent tumor resistance, as autophagy preceded by ER stress is a likely mechanism of resistance to BRAF inhibitors in melanoma (Ma et al., 2014) . In support of this, combination of Atg5 knockdown and MEK inhibition F I G U R E 6 BRAFV600 melanomas express higher levels of Snail1, which decrease upon autophagy blockade. Statistical analysis was performed using ANOVA and Bonferroni tests (*p < .05; **p < .01; ***p < .001; n.s., non-significant). (n) SNAI1 expression in BRAFV600E and BRAFWT melanoma samples using normalized mRNA expression data from TCGA database. (o) Graph and representative images (magnifications 10× and 40×) of nuclear four-tiered (0-3) score immunostaining of Snail1 in biopsies with BRAF characterized mutation. The statistical analysis was performed using Mann-Whitney test (*p < .05; **p < .01; ***p < .001; n.s., non-significant) [Colour figure can be viewed at wileyonlinelibrary.com] increases cell death in vemurafenib-resistant melanoma cell lines (Martin et al., 2015) .
Importantly, autophagy also plays a role in melanoma metastasis.
For instance, Xie et al. showed that autophagy inhibition by deletion of Atg7 or treatment with CQ suppresses melanoma tumor growth and increases survival of mice driving oncogenic BRAFV600E expression and PTEN deficiency in melanocytes (Xie, Koh, Price, White, & Mehnert, 2015) . Furthermore, CQ reduces tumor growth and impairs melanoma cell invasion and metastasis . In addition, Sharifi and coworkers revealed that autophagy inhibition reduces cell migration and invasion (in breast cancer and melanoma) and attenuates the induction of metastasis by disrupting the focal adhesion turnover . We studied the role of autophagy in the migration/invasion of BRAFV600E and NRAS mel-
anomas. Our results demonstrate that TTCC blockers, mibefradil and pimozide, impair migration and invasion of BRAFV600E cells, an effect exerted also by CQ or Atg5 knockdown. In contrast, cell motility in vitro is largely unaffected by autophagy inhibition in NRAS melanoma cell lines.
We evaluated Snail1 expression, a master transcription factor that induces EMT and invasion in melanoma cells (Hao et al., 2012; Olmeda et al., 2007) . Our results indicate that Snail1 expression is higher in BRAFV600E melanoma cells compared with BRAFWT cells. Interestingly, Snail1 levels decrease when autophagy is blocked by chloroquine or by TTCC blockers, thus inhibiting migration and invasion. Furthermore, when we overexpressed Snail1 in NRAS mutant melanoma cell line, we show an impairment of migration/invasion abilities when autophagy is blocked. Therefore, autophagy appears to regulate cell motility through different mechanisms depending on the cell type and context (Kenific, Thorburn, & Debnath, 2010) .
BRAF and NRAS mutations are mutually exclusive in melanoma (Davies et al., 2002) . Common to them is the direct or concomitant hyperactivation of signaling pathways like MEK-ERK and PI3K (Griewank et al., 2014; Vu & Aplin, 2016) . However, our studies indicate that BRAFV600E and NRASQ61 activate distinct cellular mechanisms related to melanoma progression. It has been shown that activation of ERK, the main target of BRAFV600E, is an upstream signaling mechanism responsible for high constitutive Snail1 expression in melanoma cells (Massoumi et al., 2009 ). In addition, Snail1 knockdown disrupts tumor growth and impairs melanoma progression and migration, similar to results reported here (Hao et al., 2012; Massoumi et al., 2009 ).
In BRAFV600E melanomas, the phosphorylation of cortactin and the exocyst subunit Exo70 upon ERK activation, which regulates the secretion of matrix metalloprotease-2, appears as a relevant mechanism for cell migration (Lu et al., 2016; Sandri et al., 2016) .
Our findings reveal an unknown link between autophagy and Snail1 expression that regulates the migration and invasion of BRAFV600E melanoma cells. It has been described that p62 modulates the stability of Snail1, a mediator of TGFβ/Smad signaling, through its UBA domain (Bertrand et al., 2015) . New evidences indicate that autophagy is not only involved in the intracellular degradation of damaged proteins, but also plays an important role in protein secretion (Kraya et al., 2015; Narita et al., 2011) .
In addition, autophagy-related secretion affects the tumor microenvironment and reflects the autophagy dynamics of tumor cells (Kraya et al., 2015) . A recent paper further revealed that the TGFβ/Snail signaling pathway induces EMT-like process in a paracrine manner in melanoma (Lv et al., 2017) . Moreover, knockout mice of GABARAP, an Atg8/LC3 family member implicated in the induction of autophagy, showed reduced amounts of TGFβ in serum and inhibition of tumor initiation and progression, through the enhancement of both antitumor immunity and cell death signaling (Salah et al., 2016) . Therefore, all these data may suggest that the secretion of TGFβ through autophagy could lead to increased expression of Snail1, during the induction of migration/ invasion of BRAFV600E melanoma cells. Nevertheless, the mechanism by which Snail1 levels decrease upon autophagy blockade in BRAFV600E melanoma cells requires further investigation. A possibility would be that Snail1 proteasomal degradation (Muqbil, Wu, Aboukameel, Mohammad, & Azmi, 2014 ) is deregulated after autophagy blockade.
In conclusion, our findings indicate that BRAV600E melanoma cells display higher levels of the Cav3.1 TTCC and an increased basal autophagy, compared with other types of melanoma cells.
In addition, the migration and invasion capabilities of BRAFV600E cells are sensitive to the genetic ablation or pharmacological inhibition of autophagy and depend on Snail1 levels. Thus, chemotherapeutic strategies targeting TTCCs and/or autophagy appear especially suitable to tackle metastasis in the most common type of melanoma.
| ME THODS
| Cell lines
Twelve human malignant melanoma cell lines were used and sequenced (BRAF or NRAS mutation) (Table S1 ). For cell culture conditions, see Supplemental Experimental Procedures. 
| Real-time RT-PCR
| Western blot
Melanoma cells were lysed in 2% sodium dodecyl sulfate (SDS), 125 mM Tris-HCl, pH 6.8. Western blot was conducted as described (Arindam Das et al., 2013) . The antibodies used are detailed in Supplemental Experimental Procedures.
| Immunofluorescence
Melanoma cells were fixed with 100% methanol (10 min 4°C), and blocked with 0.2% Triton X-100 (1 hr RT). Cells were incubated with anti-MAP1LC3B (1:200, rabbit polyclonal, Cell Signaling Technology, 4°C o/n).
| Lentiviral infection
The lentiviral vector containing the sequences of the shRNA of 
| Wound healing
A confluent monolayer of cells was scratched with yellow tip.
Thereafter, cells were treated, and we captured an image of the scratch at time 0 hr and after 24 hr to calculate the percentage of the wound filled by cells. For time-lapse wound-healing assay movies, see Data S1 .
| Single-cell migration assay
Cells were plated at low density (6000 cell/cm 2 ) to minimize cell-cell interactions. Cells were treated and captured an image every 20 min for 20 hr. Cells were tracked using ImageJ plugin, and the accumulated distance (μm) and the velocity (μm/hr) of the single cells were evaluated using Chemotaxis and Migration Tool (Ibidi).
| Transwell experiments
We first treated the cells during 24 hr. Then, cells were trypsinized and plated in the upper chamber of the Transwell (8 μm pore, Falcon) coated with Matrigel in serum-free medium. We used 10% of FBS as a chemoattractant. After 24 hr, cells were fixed with paraformaldehyde 4% and stained with Hoechst (5 μg/ml). Finally, cells were pictured under an epifluorescence microscope (Leica), before and after the cotton swap, and we counted (ImageJ) to have the percentage of the migrated cells.
| Tissue microarray and immunohistochemical study
One tissue microarray (TMA) was constructed from 61 formalinfixed, paraffin-embedded (FFPE) melanoma tumors (primary and metastatic Table S2 ). Assessment of TTCC immunostaining and LC3
was made as detailed in Maiques et al. (2017) . Antibodies used and IHC protocol of Snail1 and scoring, are detailed in Data S1.
| In silico studies
SNAI1 expression was analyzed in 243 human melanoma samples (109 BRAFV600E, 134 BRAFWT) from The Cancer Genome Atlas (TCGA) database (http://cancergenome.nih.gov/). Only samples with greater than 70% tumor cell content were considered. Normalized mRNA expression data were downloaded from cBioPortal (Cerami et al., 2012; Gao et al., 2013) and analyzed using GraphPad Prism.
| Ethics statement
Studies using human samples were approved by the Ethics Committee on Clinical Investigation of the Hospital Universitari Arnau de Vilanova (HUAV, Lleida, Spain), and all patients gave their informed consent.
| Statistical analysis
Statistical analysis was carried out using GraphPad Prism software.
All data were expressed as mean ± SD from at least three independ- 
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